CN102481001A - 用于食品制品的含盐微胶囊 - Google Patents
用于食品制品的含盐微胶囊 Download PDFInfo
- Publication number
- CN102481001A CN102481001A CN2010800375568A CN201080037556A CN102481001A CN 102481001 A CN102481001 A CN 102481001A CN 2010800375568 A CN2010800375568 A CN 2010800375568A CN 201080037556 A CN201080037556 A CN 201080037556A CN 102481001 A CN102481001 A CN 102481001A
- Authority
- CN
- China
- Prior art keywords
- oil
- calcium
- microcapsules
- magnesium
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 82
- 235000013305 food Nutrition 0.000 title claims abstract description 49
- 150000003839 salts Chemical class 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 12
- 239000005017 polysaccharide Substances 0.000 claims abstract description 12
- 239000011159 matrix material Substances 0.000 claims abstract description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 38
- 239000011707 mineral Substances 0.000 claims description 38
- 235000010755 mineral Nutrition 0.000 claims description 38
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 37
- 239000011575 calcium Substances 0.000 claims description 37
- 239000003921 oil Substances 0.000 claims description 37
- 235000019198 oils Nutrition 0.000 claims description 37
- 229960005069 calcium Drugs 0.000 claims description 36
- 229910052791 calcium Inorganic materials 0.000 claims description 36
- 235000001465 calcium Nutrition 0.000 claims description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000001506 calcium phosphate Substances 0.000 claims description 16
- 229920000159 gelatin Polymers 0.000 claims description 16
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 16
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 14
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 14
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 14
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 14
- 108010010803 Gelatin Proteins 0.000 claims description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims description 13
- -1 glucosaminoglycan Proteins 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 235000019197 fats Nutrition 0.000 claims description 12
- 229920001817 Agar Polymers 0.000 claims description 11
- 239000008272 agar Substances 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 7
- 239000004014 plasticizer Substances 0.000 claims description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 6
- 239000000679 carrageenan Substances 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 235000015110 jellies Nutrition 0.000 claims description 6
- 239000008274 jelly Substances 0.000 claims description 6
- 235000013336 milk Nutrition 0.000 claims description 6
- 239000008267 milk Substances 0.000 claims description 6
- 210000004080 milk Anatomy 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 239000008157 edible vegetable oil Substances 0.000 claims description 5
- 230000003203 everyday effect Effects 0.000 claims description 5
- 235000021323 fish oil Nutrition 0.000 claims description 5
- 150000003626 triacylglycerols Chemical class 0.000 claims description 5
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 208000001132 Osteoporosis Diseases 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 239000001362 calcium malate Substances 0.000 claims description 4
- 229940016114 calcium malate Drugs 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 108010006161 conchiolin Proteins 0.000 claims description 4
- 235000012343 cottonseed oil Nutrition 0.000 claims description 4
- 239000002385 cottonseed oil Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 238000005115 demineralization Methods 0.000 claims description 4
- 230000002328 demineralizing effect Effects 0.000 claims description 4
- 235000021185 dessert Nutrition 0.000 claims description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000021262 sour milk Nutrition 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 239000003760 tallow Substances 0.000 claims description 4
- 241000252203 Clupea harengus Species 0.000 claims description 3
- 241001454694 Clupeiformes Species 0.000 claims description 3
- 241000195493 Cryptophyta Species 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 241000269821 Scombridae Species 0.000 claims description 3
- 235000019513 anchovy Nutrition 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 3
- 229960002562 calcium glucoheptonate Drugs 0.000 claims description 3
- PWKNEBQRTUXXLT-ZBHRUSISSA-L calcium lactate gluconate Chemical compound [Ca+2].CC(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O PWKNEBQRTUXXLT-ZBHRUSISSA-L 0.000 claims description 3
- 229940041131 calcium lactate gluconate Drugs 0.000 claims description 3
- FATUQANACHZLRT-XBQZYUPDSA-L calcium;(2r,3r,4s,5r,6r)-2,3,4,5,6,7-hexahydroxyheptanoate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C([O-])=O FATUQANACHZLRT-XBQZYUPDSA-L 0.000 claims description 3
- OKRXSXDSNLJCRS-NLOQLBMISA-L calcium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;(2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoate;hydrate Chemical compound O.[Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.[O-]C(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O OKRXSXDSNLJCRS-NLOQLBMISA-L 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 235000013350 formula milk Nutrition 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 235000019514 herring Nutrition 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 235000020640 mackerel Nutrition 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 235000002538 magnesium citrate Nutrition 0.000 claims description 3
- 229960003543 magnesium pidolate Drugs 0.000 claims description 3
- 229940091250 magnesium supplement Drugs 0.000 claims description 3
- JQAACYUZYRBHGG-QHTZZOMLSA-L magnesium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Mg+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 JQAACYUZYRBHGG-QHTZZOMLSA-L 0.000 claims description 3
- 108700024047 pangamic acid Proteins 0.000 claims description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 3
- 229940119224 salmon oil Drugs 0.000 claims description 3
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 claims description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 claims description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 2
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 101710186708 Agglutinin Proteins 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000856 Amylose Polymers 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 2
- 229920002567 Chondroitin Polymers 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- 108010068370 Glutens Proteins 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 101710146024 Horcolin Proteins 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 101710189395 Lectin Proteins 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 2
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 2
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 102000008934 Muscle Proteins Human genes 0.000 claims description 2
- 108010074084 Muscle Proteins Proteins 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 claims description 2
- 108010084695 Pea Proteins Proteins 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- 241001125048 Sardina Species 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 229920002494 Zein Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 239000000910 agglutinin Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000020194 almond milk Nutrition 0.000 claims description 2
- 239000010775 animal oil Substances 0.000 claims description 2
- 239000010480 babassu oil Substances 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 2
- 235000011092 calcium acetate Nutrition 0.000 claims description 2
- 239000001639 calcium acetate Substances 0.000 claims description 2
- 229960005147 calcium acetate Drugs 0.000 claims description 2
- 235000010376 calcium ascorbate Nutrition 0.000 claims description 2
- 239000011692 calcium ascorbate Substances 0.000 claims description 2
- 229940047036 calcium ascorbate Drugs 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229960002713 calcium chloride Drugs 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- 229960004256 calcium citrate Drugs 0.000 claims description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 2
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 claims description 2
- 235000011038 calcium malates Nutrition 0.000 claims description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 2
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 claims description 2
- QXDHJHQRJCJRAU-UHFFFAOYSA-N calcium;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Ca].OC(=O)CC(O)(C(O)=O)CC(O)=O QXDHJHQRJCJRAU-UHFFFAOYSA-N 0.000 claims description 2
- UZWMCCLZMHPPKW-UHFFFAOYSA-L calcium;2-oxopropanoate Chemical compound [Ca+2].CC(=O)C([O-])=O.CC(=O)C([O-])=O UZWMCCLZMHPPKW-UHFFFAOYSA-L 0.000 claims description 2
- PBUBJNYXWIDFMU-UHFFFAOYSA-L calcium;butanedioate Chemical compound [Ca+2].[O-]C(=O)CCC([O-])=O PBUBJNYXWIDFMU-UHFFFAOYSA-L 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 229940071162 caseinate Drugs 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 229920006184 cellulose methylcellulose Polymers 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- 235000012716 cod liver oil Nutrition 0.000 claims description 2
- 239000003026 cod liver oil Substances 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000011950 custard Nutrition 0.000 claims description 2
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- 235000019621 digestibility Nutrition 0.000 claims description 2
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000010944 ethyl methyl cellulose Nutrition 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 235000013341 fat substitute Nutrition 0.000 claims description 2
- 239000003778 fat substitute Substances 0.000 claims description 2
- 235000012055 fruits and vegetables Nutrition 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 235000021312 gluten Nutrition 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 229920000591 gum Polymers 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000004337 magnesium citrate Substances 0.000 claims description 2
- 229960005336 magnesium citrate Drugs 0.000 claims description 2
- 239000001755 magnesium gluconate Substances 0.000 claims description 2
- 229960003035 magnesium gluconate Drugs 0.000 claims description 2
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 2
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 claims description 2
- 239000000626 magnesium lactate Substances 0.000 claims description 2
- 235000015229 magnesium lactate Nutrition 0.000 claims description 2
- 229960004658 magnesium lactate Drugs 0.000 claims description 2
- QWLHYYKDLOVBNV-UHFFFAOYSA-L magnesium orotate Chemical compound [Mg+2].[O-]C(=O)C1=CC(=O)NC(=O)N1.[O-]C(=O)C1=CC(=O)NC(=O)N1 QWLHYYKDLOVBNV-UHFFFAOYSA-L 0.000 claims description 2
- 229960000407 magnesium orotate Drugs 0.000 claims description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 2
- 239000004137 magnesium phosphate Substances 0.000 claims description 2
- 229960002261 magnesium phosphate Drugs 0.000 claims description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 2
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 229960003390 magnesium sulfate Drugs 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 2
- NFFJLMKHRCXLJO-UHFFFAOYSA-L magnesium;2-aminobutanedioate Chemical compound [Mg+2].[O-]C(=O)C(N)CC([O-])=O NFFJLMKHRCXLJO-UHFFFAOYSA-L 0.000 claims description 2
- 235000013310 margarine Nutrition 0.000 claims description 2
- 239000003264 margarine Substances 0.000 claims description 2
- 229920003087 methylethyl cellulose Polymers 0.000 claims description 2
- 235000020166 milkshake Nutrition 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 claims description 2
- 229920001206 natural gum Polymers 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000003346 palm kernel oil Substances 0.000 claims description 2
- 235000019865 palm kernel oil Nutrition 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 229940055705 pangamic acid Drugs 0.000 claims description 2
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 claims description 2
- 235000019702 pea protein Nutrition 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010408 potassium alginate Nutrition 0.000 claims description 2
- 239000000737 potassium alginate Substances 0.000 claims description 2
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 2
- 235000011962 puddings Nutrition 0.000 claims description 2
- 239000010499 rapseed oil Substances 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 108010048734 sclerotin Proteins 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 235000021147 sweet food Nutrition 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000013618 yogurt Nutrition 0.000 claims description 2
- 239000005019 zein Substances 0.000 claims description 2
- 229940093612 zein Drugs 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229940095672 calcium sulfate Drugs 0.000 claims 1
- 235000011132 calcium sulphate Nutrition 0.000 claims 1
- 239000011149 active material Substances 0.000 abstract 1
- 239000001993 wax Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 8
- 239000002775 capsule Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000013871 bee wax Nutrition 0.000 description 6
- 239000012166 beeswax Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 239000011257 shell material Substances 0.000 description 4
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 239000004203 carnauba wax Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229960001484 edetic acid Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000012164 animal wax Substances 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 229960001714 calcium phosphate Drugs 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 239000012184 mineral wax Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000002088 nanocapsule Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000012168 ouricury wax Substances 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LUPNKHXLFSSUGS-UHFFFAOYSA-M sodium;2,2-dichloroacetate Chemical compound [Na+].[O-]C(=O)C(Cl)Cl LUPNKHXLFSSUGS-UHFFFAOYSA-M 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 239000012178 vegetable wax Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- PESZCXUNMKAYME-UHFFFAOYSA-N Citroflex A-4 Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)C(C(C)=O)C(=O)OCCCC PESZCXUNMKAYME-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000011892 Von Kossa's method Methods 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- RZAPELUKMZWLLG-UHFFFAOYSA-N acetic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O RZAPELUKMZWLLG-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229940092124 calcium citrate malate Drugs 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 229960002283 calcium glubionate Drugs 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910001576 calcium mineral Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229960003144 calcium pangamate Drugs 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- JWLAOERSRUNGEF-JQVJEGKNSA-L calcium;(2r,3s,4r,5r)-6-[2-(dimethylamino)acetyl]oxy-2,3,4,5-tetrahydroxyhexanoate Chemical compound [Ca+2].CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O JWLAOERSRUNGEF-JQVJEGKNSA-L 0.000 description 1
- MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 108010059642 isinglass Proteins 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229960001983 magnesium aspartate Drugs 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229940099427 potassium bisulfite Drugs 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000020195 rice milk Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000013528 soy cheese Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
- A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
- A23G9/325—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
本发明涉及通过含有蛋白质多糖壳基质和含食用盐的活性材料的微胶囊将食用盐递送到食品制品中的组合物。
Description
发明背景
对于食品配方设计师和开发者来说用钙来强化食品制品是持续的挑战。大多数钙盐在水性介质中特别是在热加工期间反应性非常强，其通常导致不希望的功能和感觉结果诸如沉淀、絮凝、沉降和砂样口感。微溶的或不溶的钙盐已成功地加入选择的食品制剂中；然而，其宽泛的使用受需要将粉末磨碎成亚微米粒度所限制。尽管其对口感有积极影响，但是微粉化扩大了粒子的表面积，使其对相互作用更加敏感。此外，通常发现粒度减小工艺是极其劳动密集的且成本过高的。
一种扩展活性组分在食品中以及其它生物系统中的利用的方法是通过微囊化，由此将矿物质、调味剂、香料或其它生物活性物或无机活性物的粒子或分子放入可保护粒子或分子免受其微环境影响的保护性基质中，因此限制其移动性和相互作用，但最重要的是控制其释放。
在过去的二十年中已报道了微胶囊设计及方法技术中上重要进展。技术诸如流化床粒子包覆、喷雾干燥、冷冻干燥、挤压、共挤压、乳化、凝聚及其组合已有效地用于微封装多种活性成分。尽管存在这些进步，但由于很多技术原因，封装矿物质特别是钙仍然是一个挑战，特别是食品强化应用需要的高浓度元素钙。例如，对于成人，当前美国对钙的推荐每日供给量(RDA)与11mg锌或27mg铁相比是1200mg每单位食品。
US 6468568B1描述了用于封装钙和其它矿物质的挤压系统，该系统利用热熔挤压而埋入玻璃状糖基质中，随后磨碎成希望的粒度。尽管其存在高流通量和经济优势，但利用该方法制备的微胶囊的使用完全局限于表面喷洒及其它低湿度应用。WO 03/095085A1专利声明了用于食品强化应用的已通过乙二胺四乙酸(EDTA)和食品级蛋白质来稳定的钙纳米胶囊。由于管制关注以及这种螯合剂对其它矿物质的生物利用度的潜在干扰，EDTA的存在可严格地限制这种纳米胶囊在很多食品系统中的使用。WO2007/062723A1描述了具有增强的稳定性和生物利用度的稳定的纳米尺寸钙胶囊的制备。尽管存在生产这种粒子的技术优势，但是该发明具有两个主要限制。首先，强化食品制品中获得的钙水平低，其次，食品工业近期关注利用纳米粒子和/或公开其掺入到食品制剂中的管制政策。
含有钙和明胶的组合物已相当广泛地使用，由此掺入极小量的钙来帮助加强壳材料，但是对于营养强化应用来说是不够的。US 2004/0091544A1公开了药物口服制剂诸如胰岛素，其包覆在纤维素或磷酸钙的粒子上并进一步封装在明胶胶囊中或可压制成片剂。
JP 61-115019A声明了明胶膜中含有磷酸钙的药物制剂。声明当口服施用时，胶囊在消化道中迅速溶解以立即释放药物。通过混合明胶、甘油、钙磷灰石(calcium apatite)和水来制备胶囊膜。
而且，由于壳材料分解且随后从微胶囊中释放矿物盐，现有技术发展水平的微胶囊在水性介质中缺乏稳定性。这种稳定性缺乏表明强化具有高度或中等含水量的食品的重要缺陷。
因此，对于用高浓度钙强化食品制剂以满足消费者每日需求，而在成品的功能方面或感觉方面不存在不良影响的稳定的递送系统仍然存在需求。
发明详述
本发明提供了含有至少一种矿物盐的稳定的微胶囊，其中所述矿物盐完全隔离在微胶囊内。在本发明的上下文中，稳定的微胶囊指在疏水介质和/或亲水介质中微胶囊均能够维持其形状和尺寸。
本发明的稳定的微胶囊包括蛋白质多糖壳基质(protein-polysaccharideshell matrix)和芯(core)，所述芯包括至少一种矿物盐的水分散体或溶液在食用油中的乳状液，所述矿物盐被放入微胶囊的芯中，且所述矿物盐与蛋白质多糖基质隔离。这种组装提供了微胶囊在水性介质中或具有高度或中等含水量的食品制剂中的稳定性。微胶囊的结构允许掺入高浓度的那些矿物质并减小对食品制品的功能方面和感觉方面的任何负面影响。
在本发明的实施方案中，稳定的微胶囊的蛋白质选自但不限于包括以下的组：明胶、酪蛋白和酪蛋白酸盐、乳清蛋白、大豆蛋白、豌豆蛋白、小麦蛋白、玉米蛋白、大麦蛋白、卵蛋白、肌肉蛋白、来自其它豆类和根茎类的蛋白、糖蛋白诸如软骨素、葡糖胺聚糖或凝集素及其组合。在本发明优选的实施方案中，蛋白质是明胶。
在本发明的实施方案中，稳定的微胶囊的多糖选自但不限于包括以下的组：琼脂；低聚果糖(fructo-oligosaccharide)，诸如菊粉；淀粉，改性淀粉和天然淀粉及包括直链淀粉和支链淀粉的淀粉部分(starch fraction)；果胶，诸如低甲氧基果胶或高甲氧基果胶；藻酸盐，诸如藻酸钠或藻酸钾；天然树胶及合成树胶，诸如阿拉伯树胶、结冷胶(gellan gum)、韦兰胶(welangum)、黄蓍胶、黄原胶、瓜耳胶或刺槐豆胶；纤维素，诸如羧甲基纤维素、羟丙基纤维素、羟甲基纤维素、羟丁基羧甲基纤维素、羟丙基乙基纤维素或甲基乙基纤维素；短醒霉多糖；角叉菜胶，诸如α-角叉菜胶、γ-角叉菜胶、ι-角叉菜胶、κ-角叉菜胶或λ-角叉菜胶；及其组合。在本发明优选的实施方案中，多糖是琼脂。
在本发明的实施方案中，矿物盐可以是可溶性矿物盐或不溶性矿物盐。优选地，可溶性矿物盐或不溶性矿物盐是二价矿物盐。不溶性矿物盐指在25℃下在水中溶度积优选为10-5或更少的盐。可以掺入本发明的微胶囊中的二价矿物盐选自但不限于包括以下的组：磷酸三钙、磷酸氢钙、磷酸二氢钙、焦磷酸钙、碳酸钙、氢氧化钙、氧化钙、珊瑚钙(coral calcium)、羟磷灰石钙(calcium hydroxyapatite)、硫酸钙、柠檬酸钙、氯化钙、苹果酸钙、乳酸钙、抗坏血酸钙、醋酸钙、琥珀酸钙、丙酮酸钙、柠檬酸-苹果酸钙(calcium citrate-malate)、葡萄糖酸钙、乳酸-葡萄糖酸钙(calciumlactate-gluconate)、葡乳醛酸钙(calcium glubionate)、甘油磷酸钙、葡庚糖酸钙(calcium glucoheptonate)、潘氨酸钙(calcium pangamate)、硫酸镁、磷酸镁、焦磷酸镁、碳酸镁、氢氧化镁、氧化镁、氯化镁、柠檬酸镁、柠檬酸三镁(trimagnesium citrate)、葡萄糖酸镁、乳酸镁、天冬氨酸镁(magnesium aspartate)、乙酰丙酸镁、吡咯烷酮酸镁(magnesium pidolate)、乳清酸镁(magnesium ororate)及其组合。在本发明优选的实施方案中，二价矿物盐是磷酸三钙(TCP)。
本发明的微胶囊中矿物盐的量在微胶囊总重量的0.01-60％，优选在0.1-40％，且最优选在1-20％的范围内变化。
本发明的稳定的微胶囊中含有的乳状液的食用油是食品级油，并选自包括以下的组：植物油诸如大豆油、棕榈仁油、棕榈油、菜子油、红花油、亚麻子油、月见草油、芝麻油、葵花子油、低芥酸菜子油、棉子油、巴巴苏油、橄榄油或藻油(algae oil)，动物源脂肪诸如猪油，牛脂，海生动物油(marine oil)，鱼油诸如沙丁鱼油、鱼肝油、步鱼油(menhaden oil)、鲑鱼油(salmon oil)、鲱鱼油(herring oil)、鲭鱼油(mackerel oil)或鲚鱼油(anchovies oil)，它们可被分级、部分氢化和/或酯交换，及其混合物。也可以使用食用的减少的脂肪(edible reduced-fat)或低卡路里脂肪或非消化性脂肪、脂肪替代物或合成脂肪，诸如蔗糖聚酯、来自植物来源的天然存在的甘油三酯、合成甘油三酯及脂肪酸的天然甘油三酯，多不饱和脂肪酸(PUFA)的烷基酯或甘油三酯的商用混合物诸如Incromega、
或
中链甘油三酯油(MCT油)，及其混合物。在本发明优选的实施方案中，食用油是中链甘油三酯油(MCT油)。MCT油可以优选具有6-12个碳原子，最优选8-12个碳原子的脂肪酸链长。可用于本发明中的中链甘油三酯可包括例如商用混合物，诸如辛酸甘油三酯/癸酸甘油三酯(
GTC/C)、三辛酸/癸酸甘油酯(
810和812)、
M5、Bergabest MCT油、玉米油、花生油、单油酸甘油酯
或及其混合物。
本发明的稳定的微胶囊可以任选地包括至少一种增塑剂。增塑剂选自但不限于包括以下的组：甘油；山梨糖醇；麦芽糖醇；丙二醇；聚乙二醇；葡萄糖；蔗糖；羊毛脂；棕榈酸；油酸；硬脂酸；脂肪酸诸如硬脂酸或棕榈酸的金属盐，硬脂酸钠、硬脂酸钾；甘油卵磷脂(glyceryl lecithin)；单硬脂酸甘油酯；单硬脂酸丙二醇酯；乙酰化甘油酯诸如乙酰化单甘油酯或三醋酸甘油酯；柠檬酸的烷基酯诸如柠檬酸三乙酸酯、柠檬酸三丁酯、乙酰柠檬酸三丁酯或乙酰柠檬酸三乙酯；邻苯二甲酸酯诸如邻苯二甲酸二乙酯；蜡，例如天然蜡和合成蜡，动物蜡诸如蜂蜡，植物蜡诸如巴西棕榈蜡(carnauba wax)、小烛树蜡或小冠巴西棕蜡，氢化植物油诸如大豆油或棉子油，石油蜡诸如聚氨酯蜡、聚乙烯蜡、石蜡或微晶蜡，矿物蜡诸如地蜡(ozokerite)，脂肪蜡(fatty wax)，失水山梨糖醇单硬脂酸酯，牛脂；及其混合物。在本发明优选的实施方案中，增塑剂是甘油。增塑剂含量的范围可以是微胶囊总重量的0.01-10％，优选在0.05-8％，且最优选在0.1-5％。
为了对微胶囊提供另外的浮力并减小其沉降在给定的液体制剂的底部的趋势，本发明的微胶囊可以任选地包括至少一种蜡。蜡可以是微胶囊基质的组分和/或可用作微胶囊表面上的外部包衣。蜡选自包括以下的组：天然蜡和合成蜡，动物蜡诸如蜂蜡，植物蜡诸如巴西棕榈蜡、小烛树蜡或小冠巴西棕蜡，氢化植物油诸如大豆油或棉子油，石油蜡诸如聚氨酯蜡、聚乙烯蜡、石蜡或微晶蜡，矿物蜡诸如地蜡(ozokerite)，脂肪蜡，失水山梨糖醇单硬脂酸酯，牛脂，及其混合物。
在本发明的实施方案中，本发明的稳定的微胶囊的直径在0.1微米至15毫米之间，优选在1微米至10毫米之间，且最优选在10微米至5毫米之间。
本发明的稳定的微胶囊可通过食品及医药工业中任何已知的不同的技术来制备：喷雾干燥、冷冻干燥、挤出、共挤出、乳化、凝聚及其组合。在优选的实施方案中，微胶囊通过凝聚方法制备。
本发明还提供了用于形成本发明稳定的微胶囊的凝聚方法，然而微胶囊在油浴中形成并回收。允许通过重力控制滴落机制到冷油浴中来形成多糖、蛋白质和矿物盐的油乳液的凝聚体(coacervate)的小滴。由于微胶囊在疏水性介质和/或亲水性介质中的广泛使用，冷油浴对微胶囊提供了另外的稳定性。小滴经过的距离可根据溶液的粘度和/或期望的小滴尺寸来调节。
本发明的凝聚方法中使用的油浴中的油选自食品级油的组，优选MCT。油浴的温度小于30℃，优选小于15℃，其最优选在1-10℃之间。
在优选的实施方案中，本发明方法中的凝聚的微胶囊通过混合含有明胶和琼脂的水相与MCT油中含有磷酸三钙水分散体的乳相而形成。
本发明还提供了含有本发明稳定的微胶囊的强化食品制品。本发明的强化食品制品是富含矿物质的，但没有表现出不利的感官作用，诸如苦味、垩白、含沙或砂样口感。
本发明的强化食品制品含有按重量计0.5％-50％，优选1-40％，且最优选5-30％的所述微胶囊。
在本发明的实施方案中，本发明的强化食品制品的微胶囊中所含的矿物盐是钙矿物盐。
在本发明的实施方案中，稳定的微胶囊可以含有来自天然来源或合成来源的一种或多种食品级防腐剂。防腐剂例如选自但不限于包括以下的组：山梨酸的盐、二氧化硫、亚硫酸氢钠、亚硫酸氢钾、丙酸钙、硝酸钠、亚硝酸钠、丁羟茴醚、丁羟甲苯、乳酸和乳酸盐、葡糖酸盐，及其混合物。
在本发明的实施方案中，也可包括抗氧化剂，诸如，例如，但不限于丁羟甲苯(BHT)、丁羟茴醚(BHA)、叔丁基对苯二酚(TBHQ)，没食子酸酯诸如没食子酸丙酯、生育酚诸如维生素E醋酸酯、抗坏血酸、抗坏血酸盐及酯诸如抗坏血酸棕榈酸盐(酯)或抗坏血酸醋酸盐(酯)，及其混合物。
在本发明的实施方案中，本发明的稳定的微胶囊还可包括但不限于在食品工业中通常使用的其它添加剂，诸如着色剂、调味剂、增香剂，味道改良剂诸如糖、增甜剂、酸味剂、苦味剂、涩味剂(astringent agent)、成味剂，及其混合物。
本发明的强化食品制品适合于人类或动物消耗，并还可以是专用食品诸如婴儿食品、医药食品、运动食品、功能食品或营养棒。在本发明的实施方案中，强化食品制品包括但不限于果冻型甜食、水果蜜饯和蔬菜蜜饯，乳制品诸如牛奶、婴儿配方奶粉、酸奶、奶酪、奶油、人造奶油、奶昔或冰淇淋，大豆制品诸如豆乳、大豆酸奶或豆乳酪(soy cheese)，植物合成乳诸如杏仁乳或米乳(rice milk)，饮料，糖浆，甜点诸如布丁、乳蛋糕或其它糊状食品或奶油食品，及糖果制品(confectionary formulation)，诸如口香糖、巧克力、耐嚼糖果、硬糖(hard candy)、硬糖(boiled candy)、焦糖、软糖(fudge)、果冻、橡皮糖(gummy)、明胶糖或硬芯糖和软芯糖。微胶囊可以被直接地加入强化食品制品中，或可被放置在单独的囊(sachet)中。本发明的微胶囊可被直接加入即食甜点或儿童制品中的果冻型制品。
在本发明的实施方案中，强化食品制品的每单位部分的所述强化食品制品中包含成人的矿物质需求的100％推荐每日供给量(RDA)。掺入本发明微胶囊中的高浓度矿物盐允许制备出含有足够量的矿物质以达到成人的RDA摄入的强化食品制品。在本发明的优选的实施方案中，矿物质是钙。
本发明还提供了用于递送成人的矿物质需求的100％推荐每日供给量的方法，其包括施用含有本发明的微胶囊的强化食品制品。优选地，矿物质是钙。
本发明还提供了用于治疗和/或预防骨质脱矿(demineralization)、骨质疏松症或额外钙需求的方法，其包括施用足够量的含有本发明的钙微胶囊的强化食品制品。对于例如怀孕女性、泌乳女性或绝经后女性推荐RDA以上的额外钙需求量。儿童也需要补充钙的摄入。
因此，本发明还提供了微胶囊在制备用于治疗或预防骨质脱矿、骨质疏松症或额外钙需求量的强化食品制品中的用途。
还通过以下非限制性实施例对本发明进行了说明，除非另外指明，其中份、百分比、比例和比率全部按重量计，且温度全部以℃计。
附图简述
图1显示了用Leica MZFLIII共聚焦显微镜以25x放大拍摄的含TCP的微胶囊的截面的共聚焦显微照片，其中钙芯被琼脂-明胶凝聚壳包围。钙专一性染色(Von Kossa法)显示随着钙含量增加而增加的强度(0-15％TCP)。染色表明，钙被完全放入微胶囊的芯中，且完全与多糖蛋白质基质隔离。
实施例
bloom值240的B型鱼明胶(pH 5.71)获自Lapi Gelatin，意大利，且琼脂由Quimivita(西班牙)提供。细粒度(平均3微米)磷酸三钙TCP由Budenheim(德国)提供，且具有60∶40的C-8∶C-12比的MCT油(Bergabest商标)由Sternchemie Lipid technology，德国提供。由CRODA(英国)提供鱼油，Incromega TG3322(甘油三酯，最少60％ω-3 PUFA)和Incromega E3322(乙酯，最少60％ω-3PUFA)。蜂蜡来自SonnebornRefined Products B.V.(荷兰)。干果冻粉由Hacendado(阿利坎特，西班牙)提供。这些实验中使用的水全部是蒸馏的并去离子的。
实施例1.制备钙微胶囊
i.制备TCP乳状液：将磷酸三钙(10g)与水(26g)混和，并利用超六角转头混合器(ultra-turrax mixer)与MCT油(16g)和甘油(2g)充分地混合以形成乳状液。
ii.制备明胶/琼脂混合物：使明胶(22g)在水(60g)中水合30分钟并加热至50℃。将琼脂(2g)分散于水(62g)中并加热至55℃，且立即加入到热明胶溶液并充分混合。
将TCP乳状液迅速加入明胶/琼脂制剂中，随后连续搅拌以形成稠厚的均质体。使后者通过0.5mm孔滴加到冷(4℃)MCT油浴中。得到的微胶囊通过过滤或倾析回收。
实施例2.以甘油作为增塑剂制备钙微胶囊
除了在明胶/琼脂制剂中加入甘油增塑剂以外，以与实施例1相似的方式制备微胶囊。
实施例3.制备鱼油微胶囊
除了在TCP乳状液中用鱼油代替MCT油以外，以与实施例1相似的方式制备微胶囊。
实施例4.制备含蜡微胶囊
除了在TCP乳状液中用蜂蜡部分代替一些MCT油以外，以与实施例1相似的方式制备微胶囊。在滴入油浴之前将凝聚混合物维持于65℃。
实施例5.制备蜡包覆的微胶囊
利用实施例1制备的微胶囊还用蜂蜡薄膜包覆。将100g钙胶囊放置于旋转盘包衣器中，并将熔化的蜂蜡的精细喷雾施加到胶囊上直到达到充分的包覆。
实施例6.将钙微胶囊掺入果冻型甜点中
使水(250ml)沸腾并缓慢地加入柠檬味干果冻粉的商用制剂(15g)。进一步搅拌混合物(根据制造商的指示)直到粉末完全溶解。加入冷水(250ml)并继续混合直到明胶溶液的温度下降至约30℃。加入实施例1的含钙微胶囊(15g)并轻轻地混合该制剂，然后将该制剂在冰箱中在4℃下冷却至少3小时。发现本发明的微胶囊在果冻制剂中在制品的保存期(3个月)内是稳定的。
实施例7.将钙微胶囊掺入底部有水果的酸奶中
将3g实施例1的钙微胶囊轻轻地与100g水果制剂混合，并在90℃下消毒3分钟。将酸奶盖在消毒的制剂上并立即放入4℃冰箱中。检查制剂的稳定性，并发现在4℃下在21天的期间内钙微胶囊是完好无损的。
Claims (15)
1.一种稳定的微胶囊，包括蛋白质多糖壳基质和芯，所述芯包括至少一种矿物盐的水分散体或溶液在食用油中的乳状液，所述矿物盐被放入所述微胶囊的所述芯中，且所述矿物盐与所述蛋白质多糖基质隔离。
2.根据权利要求1所述的微胶囊，特征在于：所述壳基质的所述蛋白质选自包括以下的组：明胶、酪蛋白和酪蛋白酸盐、乳清蛋白，来自豆类和根茎类的蛋白、大豆蛋白、豌豆蛋白、小麦蛋白、玉米蛋白、大麦蛋白，卵蛋白、肌肉蛋白、糖蛋白、软骨素、葡糖胺聚糖、凝集素及其组合。
3.根据权利要求1所述的微胶囊，特征在于：所述壳基质的所述多糖选自包括以下的组：琼脂、低聚果糖、菊粉、改性淀粉、天然淀粉、淀粉部分、直链淀粉、支链淀粉、果胶、低甲氧基果胶、高甲氧基果胶、藻酸盐、藻酸钠、藻酸钾、天然树胶、合成树胶、阿拉伯树胶、结冷胶、韦兰胶、黄蓍胶、黄原胶、瓜耳胶、刺槐豆胶、纤维素、羧甲基纤维素、羟丙基纤维素、羟甲基纤维素、羟丁基羧甲基纤维素、羟丙基乙基纤维素和甲基乙基纤维素、短醒霉多糖、角叉菜胶及其组合。
4.根据权利要求1所述的微胶囊，特征在于：所述矿物盐是二价矿物盐。
5.根据权利要求4所述的微胶囊，特征在于：所述二价矿物盐选自包括以下的组：磷酸三钙、磷酸氢钙、焦磷酸钙、碳酸钙、珊瑚钙、羟磷灰石钙、硫酸钙、柠檬酸钙、氯化钙、苹果酸钙、乳酸钙、抗坏血酸钙、醋酸钙、琥珀酸钙、丙酮酸钙、柠檬酸-苹果酸钙、葡萄糖酸钙、乳酸-葡萄糖酸钙、葡乳醛酸钙、甘油磷酸钙、葡庚糖酸钙、潘氨酸钙、硫酸镁、磷酸镁、焦磷酸镁、碳酸镁、氯化镁、柠檬酸镁、三柠檬酸镁、葡萄糖酸镁、乳酸镁、天冬氨酸镁、乙酰丙酸镁、吡咯烷酮酸镁、乳清酸镁及其组合。
6.根据权利要求1所述的微胶囊，特征在于：所述矿物盐的量的范围是所述微胶囊总重量的0.01-60％。
7.根据权利要求1所述的微胶囊，特征在于：所述乳状液的所述食用油选自包括以下的组：植物油、大豆油、棕榈仁油、棕榈油、菜子油、红花油、亚麻子油、月见草油、芝麻油、葵花子油、低芥酸菜子油、棉子油、巴巴苏油、橄榄油、藻油、动物源脂肪、猪油、牛脂、海生动物油、鱼油，沙丁鱼油、鱼肝油、步鱼油、鲑鱼油、鲱鱼油、鲭鱼油、鲚鱼油、食用的减少的脂肪、低卡路里脂肪、非消化性脂肪、脂肪替代物、合成脂肪、蔗糖聚酯、来自植物来源的天然存在的甘油三酯、脂肪酸的合成甘油三酯、脂肪酸的天然甘油三酯、多不饱和脂肪酸(PUFA)的烷基酯或甘油三酯的商用混合物、中链甘油三酯油(MCT油)、辛酸甘油三酯/癸酸甘油三酯、三辛酸/癸酸甘油酯、玉米油、花生油、单油酸甘油酯、其部分氢化衍生物及其混合物。
8.根据权利要求1所述的微胶囊，特征在于：所述微胶囊包含至少一种增塑剂。
9.根据权利要求1所述的微胶囊，特征在于：所述微胶囊包含基质中和/或作为外部包衣的至少一种蜡。
10.一种形成根据权利要求1中所述的稳定的微胶囊的凝聚方法，所述方法包括在油浴中形成并回收所述微胶囊。
11.一种强化食品制品，所述强化食品制品含有权利要求1中所述的微胶囊。
12.根据权利要求11所述的强化食品制品，其含有按重量计0.5％-50％的所述微胶囊。
13.根据权利要求11所述的强化食品制品，特征在于：所述强化食品制品选自包括以下的组：果冻型甜食、水果蜜饯和蔬菜蜜饯、乳制品、牛奶、婴儿配方奶粉、酸奶、奶酪、奶油、人造奶油、奶昔和冰淇淋、大豆制品、豆乳、大豆酸奶、豆乳酪、植物合成乳、杏仁乳、米乳、饮料、糖浆、甜点、布丁、乳蛋糕、糊状食品、奶油食品及糖果制品。
14.根据权利要求11所述的强化食品制品，特征在于：所述强化食品制品的每单位部分的所述强化食品制品中包含成人的矿物质需求的100％推荐每日供给量。
15.根据权利要求1所述的稳定的微胶囊在制备用于治疗和/或预防骨质脱矿、骨质疏松症或额外钙需求的强化食品制品中的用途。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20090011246 EP2292102A1 (en) | 2009-09-02 | 2009-09-02 | Microcapsules containing salts for food products |
| EP09011246.7 | 2009-09-02 | ||
| PCT/EP2010/005362 WO2011026612A1 (en) | 2009-09-02 | 2010-09-01 | Microcapsules containing salts for food products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102481001A true CN102481001A (zh) | 2012-05-30 |
Family
ID=41328896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010800375568A Pending CN102481001A (zh) | 2009-09-02 | 2010-09-01 | 用于食品制品的含盐微胶囊 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120156288A1 (zh) |
| EP (1) | EP2292102A1 (zh) |
| JP (1) | JP2013503611A (zh) |
| CN (1) | CN102481001A (zh) |
| CA (1) | CA2771131A1 (zh) |
| IN (1) | IN2012DN02548A (zh) |
| WO (1) | WO2011026612A1 (zh) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103340398A (zh) * | 2013-06-16 | 2013-10-09 | 杭州元海生物科技有限公司 | 一种以食用菌超微细粉为主要壁材的鱼油微胶囊产品的生产方法 |
| CN104054849A (zh) * | 2014-05-21 | 2014-09-24 | 上海英莱腾医药研究有限公司 | 一种高含量中链甘油三酯粉末油脂及其制备方法 |
| CN104783028A (zh) * | 2014-01-21 | 2015-07-22 | 四川亿生元科技有限公司 | 一种益生元及其加工方法 |
| CN104812380A (zh) * | 2012-09-28 | 2015-07-29 | 株式会社爱茉莉太平洋 | 含有源自植物的糖蛋白的微胶囊 |
| CN106472923A (zh) * | 2016-09-09 | 2017-03-08 | 武汉轻工大学 | 乳铁蛋白‑高甲氧基果胶速能饮品的制备方法 |
| CN106666731A (zh) * | 2016-12-29 | 2017-05-17 | 浙江新维普添加剂有限公司 | 一种稳定的脂溶性营养素微胶囊及其制备方法和应用 |
| CN106720346A (zh) * | 2016-08-08 | 2017-05-31 | 江南大学 | 一种通过优化生产工艺提高高钙奶稳定性的方法 |
| CN106998779A (zh) * | 2014-12-09 | 2017-08-01 | 洲际大品牌有限责任公司 | 包有肠溶衣的功能性食物成分以及制备包有肠溶衣的功能性食物成分的方法 |
| CN107495126A (zh) * | 2017-09-14 | 2017-12-22 | 武汉华康臣生物科技有限公司 | 一种豆基钙质营养强化食品氧化酸败防控技术 |
| CN107712543A (zh) * | 2017-09-20 | 2018-02-23 | 徐宝军 | 一种抗絮凝姜黄素微胶囊、制备方法及其应用 |
| CN111467380A (zh) * | 2020-05-13 | 2020-07-31 | 四川大学 | 一种赶黄草提取物微胶囊及其制备方法 |
| CN111557441A (zh) * | 2020-04-16 | 2020-08-21 | 江西省蚕桑茶叶研究所(江西省经济作物研究所) | 一种桑叶年糕及其制备方法 |
| CN114271369A (zh) * | 2022-01-10 | 2022-04-05 | 好维康有限责任公司 | 一种软糖基底及其制备方法 |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2523566T3 (pl) | 2010-01-12 | 2019-02-28 | Mars, Incorporated | Wieloskładnikowa karma dla zwierząt zawierająca składnik stały utworzony przez tabletkowanie ściskowe |
| WO2012134441A1 (en) * | 2011-03-29 | 2012-10-04 | Empire Technology Development Llc | Microcapsule corrosion control in reinforced concrete |
| AR087157A1 (es) | 2011-06-20 | 2014-02-26 | Gen Biscuit | Galletita saludable |
| ES2559455T3 (es) * | 2011-07-15 | 2016-02-12 | Nestec S.A. | Encapsulado de calidad alimentaria y su procedimiento de fabricación |
| US20130095210A1 (en) * | 2011-10-13 | 2013-04-18 | Pepsico, Inc. | Complex Coacervates and Aqueous Dispersions of Complex Coacervates and Methods of Making Same |
| US20130202740A1 (en) * | 2012-02-08 | 2013-08-08 | Pepsico, Inc. | Acidic Aqueous Product Comprising Oil-Containing Microcapsules and Method for the Manufacture Thereof |
| US20130251855A1 (en) * | 2012-03-21 | 2013-09-26 | Pepsico, Inc. | Aqueous product comprising oil-containing microcapsules and method for the manufacture thereof |
| CN102919857B (zh) * | 2012-10-25 | 2013-12-25 | 亿利资源集团有限公司 | 食用碳酸钙微球及其制备方法 |
| WO2014084427A1 (ko) * | 2012-11-30 | 2014-06-05 | 주식회사 이코바이오 | 알긴산을 포함하는 골관절염 예방 또는 치료용 조성물 |
| RU2542418C2 (ru) * | 2013-05-20 | 2015-02-20 | Александр Александрович Кролевец | Способ получения микрокапсул хлорида кальция, обладающих супрамолекулярными свойствами |
| CO7200056A1 (es) * | 2013-08-27 | 2015-02-27 | Univ Antioquia | Gelación iónica sobre sólidos |
| WO2015122460A1 (ja) | 2014-02-14 | 2015-08-20 | 日立化成株式会社 | 糖アルコールマイクロカプセル、スラリー及び樹脂成型物 |
| CN103947705B (zh) * | 2014-04-24 | 2015-10-28 | 隋丽梅 | 一种面粉添加剂及含有该面粉添加剂的面粉和面食 |
| GB201411196D0 (en) * | 2014-06-24 | 2014-08-06 | Dupont Nutrition Biosci Aps | Composition and use thereof |
| CA2956050C (en) | 2014-07-31 | 2023-09-12 | Amorphical Ltd. | Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate |
| EP2995205A1 (en) | 2014-09-15 | 2016-03-16 | Anabio Technologies Limited | Compositions and methods for the maintenance of adequate iron intake in a mammal |
| US20190230961A1 (en) | 2014-11-25 | 2019-08-01 | Nicholas J. Singer | Instant hot water drinks |
| US9167844B1 (en) * | 2014-11-25 | 2015-10-27 | Nicholas J. Singer | Instant hot water drinks |
| US9737090B2 (en) | 2014-11-25 | 2017-08-22 | Nicholas J. Singer | Instant hot water drinks |
| US9848617B1 (en) * | 2016-10-11 | 2017-12-26 | Taiki Product, Inc. | Coagulant composition for tofu and method of producing tofu using the same |
| CN107712900A (zh) * | 2017-10-24 | 2018-02-23 | 宝得瑞（湖北）健康产业有限公司 | 一种功能性中长链脂肪酸甘油酯微胶囊及其生产方法 |
| CN112702926A (zh) | 2018-09-24 | 2021-04-23 | 品味自然有限公司 | 用于分离味道调节剂的方法 |
| US11896685B2 (en) | 2018-10-31 | 2024-02-13 | Amorepacific Corporation | Core-shell network structure comprising biopolymer and composition comprising same |
| CN109569452A (zh) * | 2018-11-23 | 2019-04-05 | 青岛明月海藻集团有限公司 | 一种包埋钙盐微胶囊及其制备方法和应用 |
| IT201900006491A1 (it) * | 2019-05-02 | 2020-11-02 | Pnk Farm Srl | Forme farmaceutiche o nutraceutiche funzionalizzate |
| CN110403198B (zh) * | 2019-07-25 | 2022-12-16 | 邓跃进 | 一种益生菌软胶囊及其制备方法 |
| KR20210069344A (ko) | 2019-12-03 | 2021-06-11 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 효능물질 전달체 |
| CN114375993B (zh) * | 2020-10-21 | 2023-09-29 | 内蒙古伊利实业集团股份有限公司 | 复合胶体及其制备方法和应用、发酵乳及其制备方法 |
| CN114223719B (zh) * | 2021-12-27 | 2024-08-27 | 新希望乳业股份有限公司 | 一种高钙晶球及其制备方法和高钙晶球常温酸奶 |
| CN114916591A (zh) * | 2022-06-09 | 2022-08-19 | 江西维尔宝食品生物有限公司 | 一种起酥性烘焙专用可塑性粉末油脂组合物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10174861A (ja) * | 1996-12-19 | 1998-06-30 | Lion Corp | マイクロカプセル及びマイクロカプセルの製造方法 |
| WO2002005667A2 (en) * | 2000-06-16 | 2002-01-24 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
| WO2005079819A1 (en) * | 2003-06-13 | 2005-09-01 | Scepter Holdings, Inc. | Delivery systems for calcium |
| CN1678388A (zh) * | 2002-09-03 | 2005-10-05 | 弗门尼舍有限公司 | 微胶囊的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61115019A (ja) | 1984-11-09 | 1986-06-02 | Nippi Zerachin Kogyo Kk | ゼラチンカプセル皮膜 |
| US5855936A (en) * | 1997-03-21 | 1999-01-05 | Nestec S.A. | Food fortification |
| US6673380B2 (en) * | 1998-11-17 | 2004-01-06 | Mcneil-Ppc, Inc. | Fortified confectionery delivery systems and methods of preparation thereof |
| DK1065936T3 (da) * | 1998-03-23 | 2009-11-02 | Gen Mills Inc | Indkapsling af bestanddele i spiselige produkter |
| US6887493B2 (en) * | 2000-10-25 | 2005-05-03 | Adi Shefer | Multi component controlled release system for oral care, food products, nutraceutical, and beverages |
| JP2002186458A (ja) * | 2000-12-19 | 2002-07-02 | Maruo Calcium Co Ltd | 食品添加剤組成物及びこれを含有する食品組成物 |
| GB0100273D0 (en) * | 2001-01-08 | 2001-02-14 | Nestle Sa | Nutritional composition for a bone condition |
| FR2839657B1 (fr) | 2002-05-14 | 2004-08-13 | Rhodia Chimie Sa | Dispersion colloidale de nanoparticules de phosphate de calcium et d'au moins une proteine, ainsi que les nanoparticules redispersables et les particules calcinees correspondantes, procede de preparation et utilisations |
| KR20050073445A (ko) * | 2002-08-14 | 2005-07-13 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 코팅된 다가불포화 지방산 함유 입자 및 코팅된 액상 제약함유 입자 |
| US20040091544A1 (en) | 2002-11-08 | 2004-05-13 | Ruff Michael D. | Coated dibasic calcium phosphate |
| US9968120B2 (en) * | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
| WO2007062723A1 (en) | 2005-11-30 | 2007-06-07 | Unilever N.V. | Calcium fortified food product and additive |
| BRPI0709892B1 (pt) * | 2006-04-05 | 2020-12-22 | Intercontinental Great Brands Llc | sistema de liberação oral e composição para remineralização de esmalte de dente de mamíferos |
-
2009
- 2009-09-02 EP EP20090011246 patent/EP2292102A1/en not_active Withdrawn
-
2010
- 2010-09-01 WO PCT/EP2010/005362 patent/WO2011026612A1/en active Application Filing
- 2010-09-01 CA CA2771131A patent/CA2771131A1/en not_active Abandoned
- 2010-09-01 IN IN2548DEN2012 patent/IN2012DN02548A/en unknown
- 2010-09-01 US US13/393,997 patent/US20120156288A1/en not_active Abandoned
- 2010-09-01 CN CN2010800375568A patent/CN102481001A/zh active Pending
- 2010-09-01 JP JP2012527232A patent/JP2013503611A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10174861A (ja) * | 1996-12-19 | 1998-06-30 | Lion Corp | マイクロカプセル及びマイクロカプセルの製造方法 |
| WO2002005667A2 (en) * | 2000-06-16 | 2002-01-24 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
| CN1678388A (zh) * | 2002-09-03 | 2005-10-05 | 弗门尼舍有限公司 | 微胶囊的制备方法 |
| WO2005079819A1 (en) * | 2003-06-13 | 2005-09-01 | Scepter Holdings, Inc. | Delivery systems for calcium |
Non-Patent Citations (2)
| Title |
|---|
| 冷延国等: "明胶微胶囊化技术研究进展", 《明胶科学与技术》 * |
| 郭明勋等: "明胶微胶囊化技术", 《明胶科学与技术》 * |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104812380A (zh) * | 2012-09-28 | 2015-07-29 | 株式会社爱茉莉太平洋 | 含有源自植物的糖蛋白的微胶囊 |
| CN104812380B (zh) * | 2012-09-28 | 2018-05-22 | 株式会社爱茉莉太平洋 | 含有源自植物的糖蛋白的微胶囊 |
| CN103340398A (zh) * | 2013-06-16 | 2013-10-09 | 杭州元海生物科技有限公司 | 一种以食用菌超微细粉为主要壁材的鱼油微胶囊产品的生产方法 |
| CN103340398B (zh) * | 2013-06-16 | 2014-08-06 | 杭州元海生物科技有限公司 | 一种以食用菌超微细粉为主要壁材的鱼油微胶囊产品的生产方法 |
| CN104783028A (zh) * | 2014-01-21 | 2015-07-22 | 四川亿生元科技有限公司 | 一种益生元及其加工方法 |
| CN104054849A (zh) * | 2014-05-21 | 2014-09-24 | 上海英莱腾医药研究有限公司 | 一种高含量中链甘油三酯粉末油脂及其制备方法 |
| CN106998779A (zh) * | 2014-12-09 | 2017-08-01 | 洲际大品牌有限责任公司 | 包有肠溶衣的功能性食物成分以及制备包有肠溶衣的功能性食物成分的方法 |
| CN106720346A (zh) * | 2016-08-08 | 2017-05-31 | 江南大学 | 一种通过优化生产工艺提高高钙奶稳定性的方法 |
| CN106472923A (zh) * | 2016-09-09 | 2017-03-08 | 武汉轻工大学 | 乳铁蛋白‑高甲氧基果胶速能饮品的制备方法 |
| CN106666731A (zh) * | 2016-12-29 | 2017-05-17 | 浙江新维普添加剂有限公司 | 一种稳定的脂溶性营养素微胶囊及其制备方法和应用 |
| CN107495126A (zh) * | 2017-09-14 | 2017-12-22 | 武汉华康臣生物科技有限公司 | 一种豆基钙质营养强化食品氧化酸败防控技术 |
| CN107712543A (zh) * | 2017-09-20 | 2018-02-23 | 徐宝军 | 一种抗絮凝姜黄素微胶囊、制备方法及其应用 |
| CN107712543B (zh) * | 2017-09-20 | 2021-04-16 | 徐宝军 | 一种抗絮凝姜黄素微胶囊、制备方法及其应用 |
| CN111557441A (zh) * | 2020-04-16 | 2020-08-21 | 江西省蚕桑茶叶研究所(江西省经济作物研究所) | 一种桑叶年糕及其制备方法 |
| CN111467380A (zh) * | 2020-05-13 | 2020-07-31 | 四川大学 | 一种赶黄草提取物微胶囊及其制备方法 |
| CN114271369A (zh) * | 2022-01-10 | 2022-04-05 | 好维康有限责任公司 | 一种软糖基底及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2292102A1 (en) | 2011-03-09 |
| US20120156288A1 (en) | 2012-06-21 |
| WO2011026612A1 (en) | 2011-03-10 |
| JP2013503611A (ja) | 2013-02-04 |
| IN2012DN02548A (zh) | 2015-08-28 |
| CA2771131A1 (en) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102481001A (zh) | 用于食品制品的含盐微胶囊 | |
| EP0648076B1 (en) | A microencapsulated oil or fat product | |
| Palzer | Food structures for nutrition, health and wellness | |
| EP1858352B1 (en) | A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base | |
| CA2752522C (en) | Delivery of active agents using a chocolate vehicle | |
| CN101018486A (zh) | 含有可食用油的粉末组合物及其在食品中的用途 | |
| US20100247713A1 (en) | Beta + hydrolyzed lecithin | |
| CA2961699C (en) | Fatty acid composition and method for fortifying nutritional products with fatty acids | |
| CA2328320C (en) | Encapsulated long chain alcohols | |
| JP3611652B2 (ja) | コーティング粉末の製造方法 | |
| US20090130211A1 (en) | Gelled colloidal emulsion for appetite suppression | |
| US20170360735A1 (en) | Ingestible emulsion matrix for delivery of creatine | |
| EP0893953B1 (en) | Pufa coated solid carrier particles for foodstuff | |
| TWI779094B (zh) | 含有吡咯并喹啉醌的橡皮糖及其製造方法 | |
| CN101888791A (zh) | 脂溶性活性成分的粉状制剂 | |
| CN101888786A (zh) | 脂溶性活性成分的粉状制剂 | |
| JP6398181B2 (ja) | ユビキノール高含有ゲル状組成物 | |
| JP2021185808A (ja) | 水溶性機能性成分を包含するゲル状粒子を含有するグミ状組成物 | |
| JPH0352948B2 (zh) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120530 |
|
| RJ01 | Rejection of invention patent application after publication |